Dedalus UK response to COVID-19

With the rapid development of COVID-19 in the UK, Dedalus believe it’s important to be open about how we’re responding.  With family values and people at the heart of our business, we have taken the following precautions to protect our employees as well as those with whom we work.

The below information reflects our guidelines at 16th March 2020.  As the situation progresses we will update relevant points accordingly:

Remote Working

Dedalus UK has long been an advocate of providing the flexibility for employees to achieve the most relevant and efficient working balance suited to their role.  In light of current developments, the welfare of our staff and those nearest to them must comes first and as such, all employees have been asked to work remotely with effect from 12th March 2020.

Company Travel

We believe that limiting travel by shared-access transport is a sensible option to help reduce risk of infection.

Employees have been asked to cancel any pre-existing international trips, and refrain form booking future trips until further notice.  Our policy for travel within the UK advises against all but essential travel.

We ask employees returning from international travel or who have had confirmed or suspected exposure to infection at any time, to self-quarantine for 14 days.

Meetings and Events 

Whilst working on a case-by-case basis, the standard current Dedalus policy is to use audio-visual platforms for meetings, events and marketing as a default, and limit any meetings in person to no more than four people where absolutely essential.

Communications

Dedalus HR and leadership team are updating employees on the latest developments and strive to address concerns and questions where possible to provide the support needed.  All employees working with external Partners, suppliers and third parties will be communicating and working to Dedalus policies and Coronavirus guidance issued by Public Health England.

Business Continuity

In spite of the restrictions created by COVID-19, Dedalus UK is committed to maintaining the level and high standard of business support to our Customers and Partners, through

  • 24/7 call assistance
  • On-site assistance team (using protective measures)
  • Solutions which pioneer shared knowledge and collaboration, without the need for face-to-face meetings

Please email uk@dedalus.eu, should you have any enquiries related to the above.

We appreciate your continued support and wish to extend a heartfelt Thank You to all NHS hospitals, Customers and Partners who are all going above and beyond to help patients at this crucial time.


Dedalus Holding, controlled by Ardian, submits a firm offer to Agfa-Gevaert Group to buy of its healthcare software business and enters into an exclusivity agreement for the acquisition

London, 5th December 2019 – Dedalus Holding, a company 60% majority-owned by the independent private investment company Ardian, has submitted a firm offer and entered into exclusive negotiations to acquire part of Agfa-Gevaert’s healthcare software business (the “Business”).

The Business, which generates around 260 million Euro of full-year revenues, is made up of Agfa’s Healthcare Information Solutions and Integrated Care activities, as well as associated Imaging IT activities integrated into these units.

With a total turnover of 470 million Euro, the acquisition of Agfa-Gevaert’s healthcare software business will firmly establish the Dedalus Group as the European leader in the healthcare software sector, with a presence in over 30 countries and leadership positions in Italy, Germany and France.

Commenting on the news, Judy Smith, Managing Director of Dedalus Healthcare UK, said: “We are tremendously excited to be in acquisition talks with AGFA Healthcare IT.

“As the largest European provider of health information systems, we are committed to delivering integrated clinical solutions that truly revolutionise patient care. The acquisition of Agfa’s healthcare software business will ensure that we are able to further fulfil that commitment and continue to transform patient lives and ease clinical workloads.

“This development is just a taste of what is to come next year for the UK. Following the lead of our European parents, we will be launching the UK roadmap in early 2020 with an eye on growth, more intuitive solutions and, above all, a focus on our customers, providing even easier and more efficient deployment.”

Yann Chareton, Managing Director of Ardian Buyout, said: “We invested in Dedalus in 2016 to accelerate the growth of the company in Europe, as we knew that the group had all the characteristics to be able to compete successfully in its sector on a global scale.

“This acquisition in the healthcare technology space underpins ARDIAN’s strategy to support transitions of companies into undisputed leaders in their respective markets, widening their offering and geographic reach with transformational build-ups.”

 

Dedalus – Advisors

M&A Advisor: BNP Paribas, UBS, Banca IMI
Legal Advisor: Clifford Chance
Commercial Due Diligence: EY Parthenon
Financial, Tax, Operational Due Diligence: KPMG
Technology Due Diligence: Tech Economy
Debt Advisor: Rothschild

 

ABOUT DEDALUS

Dedalus Healthcare Ltd is part of the Dedalus Group, which is the largest European provider of healthcare information systems, with implementations on 5 continents, in 25 countries and a multi-million Euro R&D budget. Dedalus covers the full spectrum of healthcare solutions from digital anatomical pathology, LIMS
integration, laboratory automation, digital storage, asset tracking, population health management, e-prescribing and powerful interoperability capabilities.

 

ABOUT AGFA-GEVAERT

The Agfa-Gevaert Group develops, manufactures and distributes an extensive range of analogue and digital imaging systems and IT solutions, mainly for the printing industry and the healthcare sector, as well as for specific industrial applications.

Agfa’s headquarters and parent company are located in Mortsel, Belgium. The Agfa-Gevaert Group achieved a turnover of 2,247 million Euro in 2018.

www.agfa.com

 

ABOUT ARDIAN

Ardian is a world-leading private investment house with assets of US$96bn managed or advised in Europe, the Americas and Asia. The company is majority-owned by its employees. It keeps entrepreneurship at its heart and focuses on delivering excellent investment performance to its global investor base.

Through its commitment to shared outcomes for all stakeholders, Ardian’s activities fuel individual, corporate and economic growth around the world.

Holding close its core values of excellence, loyalty and entrepreneurship, Ardian maintains a truly global network, with more than 640 employees working from fifteen offices across Europe (Frankfurt, Jersey, London, Luxembourg, Madrid, Milan, Paris and Zurich), the Americas (New York, San Francisco and Santiago) and Asia (Beijing, Singapore, Tokyo and Seoul). It manages funds on behalf of more than 1,000 clients through five pillars of investment expertise: Fund of Funds, Direct Funds, Infrastructure, Real Estate and Private Debt.